FREQUENCY ANALYSIS OF CYCLOSPORINE-SENSITIVE CYTOTOXIC T LYMPHOCYTE PRECURSORS
- 31 October 1984
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 38 (5) , 532-535
- https://doi.org/10.1097/00007890-198411000-00019
Abstract
The influence of the immunosuppressant cyclosporine (CsA) on the antigen-driven activation of resting [mouse] cytotoxic T lymphocyte precursors (CTL-p) and on the reactivation of mixed-lymphocyte-reaction-primed CTL is analyzed at the clonal level. Using the limiting-dilution culture approach, the majority (60-90%) of clones of CTL-p with specificity for given antigens were not activated in the presence of CsA; a minority (10-40%) of CTL-p were CsA-resistant. This is so for alloantigen-reactive CTL-p and major-histocompatibility-complex-resitricted CTL-p with hapten specificity. In contrast, the frequency of CTL grown out of primed mixed lymphocyte culture cells is not influenced by CsA. Although CsA does not interfere with the short-term growth of Il-2 [interleukin-2]-drive activated T cells, it may influence the expression of their cytolytic potential.This publication has 8 references indexed in Scilit:
- Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells.The Journal of Immunology, 1983
- Cyclosporin receptors on human lymphocytes.The Journal of Immunology, 1982
- Dissection of the proliferative and differentiative signals controlling murine cytotoxic T lymphocyte responses.The Journal of Experimental Medicine, 1982
- Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.The Journal of Immunology, 1981
- Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2European Journal of Immunology, 1981
- CYCLOSPORIN-A AND STEROID-THERAPY IN 66 CADAVER KIDNEY RECIPIENTS1981
- Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process.The Journal of Immunology, 1980
- Biological effects of cyclosporin A: A new antilymphocytic agentInflammation Research, 1976